These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27221823)

  • 1. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.
    Bazzi ZA; Lanoue D; El-Youssef M; Romagnuolo R; Tubman J; Cavallo-Medved D; Porter LA; Boffa MB
    BMC Cancer; 2016 May; 16():328. PubMed ID: 27221823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis time.
    Urano T; Sano Y; Suzuki Y; Okada M; Sano H; Honkura N; Morooka N; Doi M; Suzuki Y
    Res Pract Thromb Haemost; 2024 May; 8(4):102463. PubMed ID: 39026660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of heparin interaction sites on thrombin-activatable fibrinolysis inhibitor that modulate plasmin-mediated activation, thermal stability, and antifibrinolytic potential.
    Marar TT; Boffa MB
    Res Pract Thromb Haemost; 2024 May; 8(4):102459. PubMed ID: 38983903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIa.
    Anand K; Pallares I; Valnickova Z; Christensen T; Vendrell J; Wendt KU; Schreuder HA; Enghild JJ; Avilés FX
    J Biol Chem; 2008 Oct; 283(43):29416-23. PubMed ID: 18669641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of cofactor activities of endothelial microparticle-thrombomodulin with liposomal surrogate.
    Gruzdys V; Wang L; Wang D; Huang R; Sun XL
    Biochem Biophys Res Commun; 2023 Apr; 651():79-84. PubMed ID: 36801612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets.
    Du XY; Zabel BA; Myles T; Allen SJ; Handel TM; Lee PP; Butcher EC; Leung LL
    J Biol Chem; 2009 Jan; 284(2):751-8. PubMed ID: 19010784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
    J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model.
    Jeong BY; Uddin MJ; Park JH; Lee JH; Lee HB; Miyata T; Ha H
    PLoS One; 2016; 11(6):e0157012. PubMed ID: 27258009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme.
    Garabon JJW; Boffa MB
    J Thromb Thrombolysis; 2023 Aug; 56(2):283-290. PubMed ID: 37310666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key therapeutic targets implicated at the early stage of hepatocellular carcinoma identified through machine-learning approaches.
    Hosseiniyan Khatibi SM; Najjarian F; Homaei Rad H; Ardalan M; Teshnehlab M; Zununi Vahed S; Pirmoradi S
    Sci Rep; 2023 Mar; 13(1):3840. PubMed ID: 36882466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis for clarifying transcriptomics landscapes of spread through air spaces in lung adenocarcinoma.
    Zeng Y; Zhou L; Jia D; Pan B; Li X; Yu Y
    Front Genet; 2022; 13():900864. PubMed ID: 36072669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Coagulation-Related Gene-Based Prognostic Model for Invasive Ductal Carcinoma.
    Li J; Du J; Wang Y; Jia H
    Front Genet; 2021; 12():722992. PubMed ID: 34621293
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombomodulin expression impacts the recurrence and long-term survival in pancreatic cancer.
    Sugano H; Shirai Y; Sato S; Hamatani S; Hamura R; Taniai T; Horiuchi T; Gocho T; Eto K; Ikegami T
    Ann Gastroenterol Surg; 2021 Jul; 5(4):567-574. PubMed ID: 34337305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analysis of Systemic and Tumor Microenvironment Proteomes From Children With B-Cell Acute Lymphocytic Leukemia at Diagnosis and After Induction Treatment.
    Broto GE; Corrêa S; Trigo FC; Dos Santos EC; Tomiotto-Pelissier F; Pavanelli WR; Silveira GF; Abdelhay E; Panis C
    Front Oncol; 2020; 10():550213. PubMed ID: 33381445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer.
    Ren Q; Zhu P; Zhang H; Ye T; Liu D; Gong Z; Xia X
    Cancer Cell Int; 2020; 20():92. PubMed ID: 32226313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic Analysis Reveals the Wound Healing Activity of Mussel Myticin C.
    Rey-Campos M; Moreira R; Romero A; Medina-Gali RM; Novoa B; Gasset M; Figueras A
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAFI deficiency causes maladaptive vascular remodeling after hemophilic joint bleeding.
    Wyseure T; Yang T; Zhou JY; Cooke EJ; Wanko B; Olmer M; Agashe R; Morodomi Y; Behrendt N; Lotz M; Morser J; von Drygalski A; Mosnier LO
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coagulome and the oncomir: impact of cancer-associated haemostatic dysregulation on the risk of metastasis.
    Burbury K; MacManus MP
    Clin Exp Metastasis; 2018 Apr; 35(4):237-246. PubMed ID: 29492795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.
    Viedma-Rodríguez R; Martínez-Hernández MG; Flores-López LA; Baiza-Gutman LA
    Mol Cell Biochem; 2018 Jan; 437(1-2):65-80. PubMed ID: 28612231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.
    Bazzi ZA; Balun J; Cavallo-Medved D; Porter LA; Boffa MB
    Clin Exp Metastasis; 2017 Feb; 34(2):155-169. PubMed ID: 28124276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.